Actively Recruiting
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-15
120
Participants Needed
5
Research Sites
237 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Human Endogenous Retroviruses (HERVs) are ancient sequences that became integrated into our DNA during evolutionary processes. The significance of their presence in DNA is still being studied, but HERVs appear to be involved in the regulation of the immune response. The gut microbiota is the set of microorganisms that physiologically colonize the gastrointestinal tract. Progressively increasing attention is being paid to the gut microbiota and its potential role in diseases of various kinds. In particular, it has recently been shown how abnormalities in the microbiota can affect immune regulation by determining the occurrence of certain diseases. One objective of the study is to evaluate whether there is an association between the expression of HERVs and clinical manifestations in pediatric age in patients with various diseases such as Kawasaki Disease, IgA Vasculitis/Schonlein-Henoch's Purpura, SARS-CoV-2 infection, or, finally, febrile virosis. Another objective of the study is to evaluate whether there is an association between the presence of particular types of bacteria in the gut microbiota and clinical manifestations in pediatric age in patients with Kawasaki Disease, IgA Vasculitis/Schonlein-Henoch purpura, SARS-CoV-2 infection or febrile virosis. The results from this may open new perspectives for both the care and therapeutic management of children with these diseases.
CONDITIONS
Official Title
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients newly diagnosed with Kawasaki disease
- Pediatric patients newly diagnosed with Vasculitis
- Pediatric patients newly diagnosed with SARS-CoV-2 infection
- Pediatric patients newly diagnosed with febrile virosis
- Pediatric patients with inflammatory diseases with systemic involvement
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Ospedale Ramazzini di Carpi, Azienda USL di Modena UO Pediatria
Carpi, Modena, Italy, 41012
Actively Recruiting
2
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve ed Intensiva
Bologna, Italy, 40138
Actively Recruiting
3
Azienda Ospedaliera-Universitaria di Modena
Modena, Italy, 41100
Actively Recruiting
4
IRCCS Ospedale Pediatrico Bambino Gesù UOC Pediatria Generale
Roma, Italy, 00165
Actively Recruiting
5
Ospedale Regina Margherita, Torino, UO Reumatologia Pediatrica
Torino, Italy, 10126
Actively Recruiting
Research Team
M
Marianna Fabi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here